Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Jiefei Tong
Affiliation
Hospital for Sick Children
ORCID
Career Start Year
1993
Papers
54
H Index
31
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36214668
Mitochondrial Aconitase ACO2 Links Iron Homeostasis with Tumorigenicity in Non-Small Cell Lung Cancer.
Mol Cancer Res
2023
35595168
Proteomic Characterization of a Candidate Polygenic Driver of Metabolism in Non-small Cell Lung Cancer.
J Mol Biol
2022
35383171
Integrative analysis of non-small cell lung cancer patient-derived xenografts identifies distinct proteotypes associated with patient outcomes.
Nat Commun
2022
35613471
Engineered SH2 Domains for Targeted Phosphoproteomics.
ACS Chem Biol
2022
35362478
Tankyrase represses autoinflammation through the attenuation of TLR2 signaling.
J Clin Invest
2022
32842143
Targeting the Otub1/c-Maf axis for the treatment of multiple myeloma.
Blood
2021
32903271
Cancer proteome and metabolite changes linked to SHMT2.
PLoS One
2020
31822558
The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
J Biol Chem
2020
30431205
Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.
Protein Sci
2019
31330989
Somatic Alteration Burden Involving Non-Cancer Genes Predicts Prognosis in Early-Stage Non-Small Cell Lung Cancer.
Cancers (Basel)
2019
31292163
ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
Cancer Res
2019
30713027
Structural and Functional Characterization of Ubiquitin Variant Inhibitors of USP15.
Structure
2019
30938160
Evosep One Enables Robust Deep Proteome Coverage Using Tandem Mass Tags while Significantly Reducing Instrument Time.
J Proteome Res
2019
30158528
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis.
Nat Commun
2018
27750381
Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Int J Cancer
2017
28285997
CCM-3 Promotes C. elegans Germline Development by Regulating Vesicle Trafficking Cytokinesis and Polarity.
Curr Biol
2017
28176486
Integrated analysis of proteome, phosphotyrosine-proteome, tyrosine-kinome, and tyrosine-phosphatome in acute myeloid leukemia.
Proteomics
2017
28673317
The ubiquitin-conjugating enzyme UBE2O modulates c-Maf stability and induces myeloma cell apoptosis.
J Hematol Oncol
2017
28894103
The Candida albicans transcription factor Cas5 couples stress responses, drug resistance and cell cycle regulation.
Nat Commun
2017
28933784
Inhibition of the deubiquitinase USP5 leads to c-Maf protein degradation and myeloma cell apoptosis.
Cell Death Dis
2017
27880036
Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MS.
Proteomics
2017
26825710
The ubiquitin ligase HERC4 mediates c-Maf ubiquitination and delays the growth of multiple myeloma xenografts in nude mice.
Blood
2016
27797343
Reciprocal stabilization of ABL and TAZ regulates osteoblastogenesis through transcription factor RUNX2.
J Clin Invest
2016
27152361
Identification of human plasma cells with a lamprey monoclonal antibody.
JCI Insight
2016
25587033
Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificity.
Mol Cell Proteomics
2015
25784717
CHCHD2 Is Coamplified with EGFR in NSCLC and Regulates Mitochondrial Function and Cell Migration.
Mol Cancer Res
2015
24430869
The ShcD signaling adaptor facilitates ligand-independent phosphorylation of the EGF receptor.
Mol Biol Cell
2014
25448412
Ubiquitination of the transcription factor c-MAF is mediated by multiple lysine residues.
Int J Biochem Cell Biol
2014
25429762
Integrated omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact.
Nat Commun
2014
25292214
Tyrosine phosphorylation of NEDD4 activates its ubiquitin ligase activity.
Sci Signal
2014
24797263
Proteomic analysis of the epidermal growth factor receptor (EGFR) interactome and post-translational modifications associated with receptor endocytosis in response to EGF and stress.
Mol Cell Proteomics
2014
23287719
A strategy for modulation of enzymes in the ubiquitin system.
Science
2013
23825523
Odin (ANKS1A) modulates EGF receptor recycling and stability.
PLoS One
2013
22554165
Selected Reaction Monitoring (SRM) Analysis of Epidermal Growth Factor Receptor (EGFR) in Formalin Fixed Tumor Tissue.
Clin Proteomics
2012
20815376
Primary tumor xenografts of human lung adeno and squamous cell carcinoma express distinct proteomic signatures.
J Proteome Res
2011
21609022
Quantitative phospho-proteomic profiling of hepatocyte growth factor (HGF)-MET signaling in colorectal cancer.
J Proteome Res
2011
21135258
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway.
Blood
2011
20205385
Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometry.
J Proteome Res
2010
19531499
Epidermal growth factor receptor phosphorylation sites Ser991 and Tyr998 are implicated in the regulation of receptor endocytosis and phosphorylations at Ser1039 and Thr1041.
Mol Cell Proteomics
2009
19901323
Multiple myeloma phosphotyrosine proteomic profile associated with FGFR3 expression, ligand activation, and drug inhibition.
Proc Natl Acad Sci U S A
2009
18271526
Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.
J Proteome Res
2008
16889898
Emerging applications for phospho-proteomics in cancer molecular therapeutics.
Biochim Biophys Acta
2006
12486127
Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
J Biol Chem
2003
12435363
UNC-5 function requires phosphorylation of cytoplasmic tyrosine 482, but its UNC-40-independent functions also require a region between the ZU-5 and death domains.
Dev Biol
2002
11533026
Netrin stimulates tyrosine phosphorylation of the UNC-5 family of netrin receptors and induces Shp2 binding to the RCM cytodomain.
J Biol Chem
2001
11572780
Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region.
Cell
2001
10493909
HEK-293 cells possess a carbachol- and thapsigargin-sensitive intracellular Ca2+ store that is responsive to stop-flow medium changes and insensitive to caffeine and ryanodine.
Biochem J
1999
9873004
Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
J Biol Chem
1999
10097181
A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2+ release channel function and severe central core disease.
Proc Natl Acad Sci U S A
1999
9334205
Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and/or central core disease.
J Biol Chem
1997
1 - 50 of 54
Column Actions
Search
Recommended Authors
Alexandre Rosa Campos
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year
2015
Number of shared co-authors
0
Dennis Goldfarb
Washington University School of Medicine
Career Start Year
2012
Number of shared co-authors
0
Florent Dingli
Institut Curie, PSL Research University
Career Start Year
2011
Number of shared co-authors
1
Erin D Jeffery
Agenus Inc, American Society for Mass Spectrometry, Hartwick College, Human Proteome Organisation, Large Scale Biology Corp, University of Virginia
Career Start Year
2005
Number of shared co-authors
0
Michael B Major
Washington University in St. Louis
Career Start Year
2004
Number of shared co-authors
1
Chong-Feng Xu
Biogen Inc.
Career Start Year
2004
Number of shared co-authors
0
Erik J Soderblom
Center for Genomic and Computational Biology, Duke University
Career Start Year
2003
Number of shared co-authors
0
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Career Start Year
2003
Number of shared co-authors
6
Feng Yang
Howard Hughes Medical Institute, University of California San Diego
Career Start Year
2003
Number of shared co-authors
1
Jayantha Gunaratne
Institute of Molecular and Cell Biology
Career Start Year
2000
Number of shared co-authors
0
Jeroen A A Demmers
Erasmus Medical Center
Career Start Year
2000
Number of shared co-authors
0
Rachel Toth
University of Dundee
Career Start Year
1999
Number of shared co-authors
1
Monika A Davare
Oregon Health Sciences University
Career Start Year
1998
Number of shared co-authors
0
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Damarys Loew
Institut Curie, PSL Research University
Career Start Year
1996
Number of shared co-authors
1
Forest M White
Massachusetts Institute of Technology
Career Start Year
1995
Number of shared co-authors
0
Jose Antonio Rodriguez
University of the Basque Country (UPV/EHU)
Career Start Year
1995
Number of shared co-authors
0
Manfred Koegl
Boehringer Ingelheim RCV GmbH & Co. KG
Career Start Year
1993
Number of shared co-authors
0
Ailan Guo
College of Animal Medicine, Xinjiang Agricultural University
Career Start Year
1992
Number of shared co-authors
3
Aykut Uren
Georgetown University Medical Center
Career Start Year
1991
Number of shared co-authors
0
Steven P Gygi
Harvard Medical School
Career Start Year
1991
Number of shared co-authors
6
Dirk Geerts
Amsterdam University Medical Center
Career Start Year
1989
Number of shared co-authors
0
John Rush
Cell Signaling Technology Inc.
Career Start Year
1987
Number of shared co-authors
0
Thomas A Neubert
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year
1986
Number of shared co-authors
2
Hediye Erdjument-Bromage
Neuroscience Institute, NYU Grossman School of Medicine
Career Start Year
1984
Number of shared co-authors
0
Andrew D Cherniack
Dana-Farber Cancer Institute
Career Start Year
1984
Number of shared co-authors
4
J. Wade Harper
Harvard Medical School
Career Start Year
1981
Number of shared co-authors
6
Karin D Rodland
Oregon Health and Science University
Career Start Year
1973
Number of shared co-authors
2
Tony Hunter
Salk Institute for Biological Studies
Career Start Year
1968
Number of shared co-authors
1
John R Yates
TheScripps Research Institute
Career Start Year
1960
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Michael F Moran
Hospital for Sick Children, University of Toronto
Co-authored papers
42
Paul Taylor
Hospital for Sick Children
Co-authored papers
22
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers
13
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
8
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers
7
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers
6
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers
5
Ming Li
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Suzanne Trudel
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
5
Sachdev S Sidhu
School of Pharmacy, University of Waterloo
Co-authored papers
5
Tony Pawson
Co-authored papers
4
Yuhong Wei
Rosalind and Morris Goodman Cancer Institute, McGill University
Co-authored papers
4
Vladimir Ignatchenko
Margaret Cancer Center
Co-authored papers
4
David H MacLennan
Co-authored papers
4
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Shingo Sakashita
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Co-authored papers
3
Naoki Yanagawa
Yamagata Prefectural Central Hospital
Co-authored papers
3
Dennis Wang
Sheffield Institute of Translational Neuroscience, University of Sheffield
Co-authored papers
3
Chang-Qi Zhu
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Vibha Raghavan
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
3
Jeffrey L Wrana
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Co-authored papers
3
Lei Li
Hospital for Sick Children
Co-authored papers
3
Jason Moffat
University of Toronto
Co-authored papers
2
Dan Strumpf
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Anne-Claude Gingras
Lunenfeld-Tanenbaum Research Institute
Co-authored papers
2
Thomas K Waddell
Toronto General Hospital
Co-authored papers
2
Roya Navab
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
2
Shawn S-C Li
University of Western Ontario
Co-authored papers
2
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers
2
1 - 30